Adrenergic regulation of immunity

[1]  J. Levine,et al.  β2‐Adrenergic receptor regulation of human neutrophil function is sexually dimorphic , 2004, British journal of pharmacology.

[2]  D. M. Silberman,et al.  Acute and chronic stress exert opposing effects on antibody responses associated with changes in stress hormone regulation of T-lymphocyte reactivity , 2003, Journal of Neuroimmunology.

[3]  V. Sanders,et al.  CD86 and beta2-adrenergic receptor stimulation regulate B-cell activity cooperatively. , 2005, Trends in immunology.

[4]  A. Munson,et al.  Norepinephrine and the antibody response. , 1985, Pharmacological reviews.

[5]  D. Postma,et al.  Polarized Th1 and Th2 cells are less responsive to negative feedback by receptors coupled to the AC/cAMP system compared to freshly isolated T cells , 2003, British journal of pharmacology.

[6]  F. Paliogianni,et al.  Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT. , 1996, Cellular immunology.

[7]  B. Pedersen,et al.  Exercise, nutrition and immune function , 2004 .

[8]  S. Romagnani Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.

[9]  K. Hellstrand,et al.  An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. , 1989, International archives of allergy and applied immunology.

[10]  Markus Schwaninger,et al.  A mechanism converting psychosocial stress into mononuclear cell activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  V. Sanders,et al.  Cytokine Production by Naive and Primary Effector CD4+ T Cells Exposed to Norepinephrine , 2000, Brain, Behavior, and Immunity.

[12]  G. Marshall,et al.  In vivo alteration in type-1 and type-2 cytokine balance: a possible mechanism for elevated total IgE in HIV-infected patients. , 1998, Human immunology.

[13]  J. Wagner,et al.  Catecholamines Inhibit the Antigen-Presenting Capability of Epidermal Langerhans Cells1 , 2002, The Journal of Immunology.

[14]  O. Strannegard,et al.  Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells. , 1985, Journal of immunology.

[15]  M. Kaliner,et al.  THE MODULATING INFLUENCE OF CYCLIC NUCLEOTIDES UPON LYMPHOCYTE-MEDIATED CYTOTOXICITY , 1973, The Journal of experimental medicine.

[16]  A. Khamlichi,et al.  The 3' IgH regulatory region: a complex structure in a search for a function. , 2000, Advances in immunology.

[17]  K. Madden,et al.  Effects of l-deprenyl treatment on noradrenergic innervation and immune reactivity in lymphoid organs of young F344 rats , 1999, Journal of Neuroimmunology.

[18]  R. Phipps,et al.  Elevated levels of intracellular cAMP sensitize resting B lymphocytes to immune complex‐induced unresponsiveness , 1991, European journal of immunology.

[19]  S. Rennard,et al.  Alternative Mechanisms for Long-Acting β2-Adrenergic Agonists in COPD , 2001 .

[20]  A. Ulmer,et al.  The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes. , 1975, Immunology.

[21]  P. Henricks,et al.  Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. , 1997, The American journal of physiology.

[22]  A. Kavelaars,et al.  Tissue specific effects of the β2-adrenergic agonist salbutamol on LPS-induced IFN-γ, IL-10 and TGF-β responses in vivo , 2004, Journal of Neuroimmunology.

[23]  D. Lawrence,et al.  The dietary supplement ephedrine induces b-adrenergic mediated exacerbation of systemic lupus erythematosus in NZM391 mice , 2005, Lupus.

[24]  Altered lymphocyte catecholamine reactivity in mice subjected to chronic mild stress. , 2003, Biochemical pharmacology.

[25]  B. Bonavida,et al.  Mechanism of Norepinephrine-Mediated Inhibition of Human NK Cytotoxic Functions: Inhibition of Cytokine Secretion, Target Binding, and Programming for Cytotoxicity , 2002, Brain, Behavior, and Immunity.

[26]  E. Smeland,et al.  Cyclic AMP has the ability to influence multiple events during B cell stimulation , 1988, European journal of immunology.

[27]  C. Hsueh,et al.  The conditioned enhancement of neutrophil activity is catecholamine dependent , 2005, Journal of Neuroimmunology.

[28]  J. Bijlsma,et al.  Decreased expression and activity of G‐protein‐coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  A. Rolink,et al.  B-cell-specif ic coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation , 1996, Nature.

[30]  D. Herndon,et al.  Burn‐associated Candida albicans infection caused by CD30+ type 2 T cells , 1998, Journal of leukocyte biology.

[31]  S. Felten,et al.  Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. , 1995, Journal of immunology.

[32]  H. Besedovsky,et al.  Sympathetic Abnormalities during Autoimmune Processes , 2003 .

[33]  D. Leung,et al.  Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists. , 2004, The Journal of allergy and clinical immunology.

[34]  S. Watanabe,et al.  Modulation of Th1- and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclear cells by phosphodiesterase inhibitors. , 1998, General pharmacology.

[35]  A. Kavelaars,et al.  Noradrenaline induces phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of α1-adrenergic receptors , 2000, Journal of Neuroimmunology.

[36]  S. Ben-Eliyahu The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology , 2003, Brain, Behavior, and Immunity.

[37]  I. Grants,et al.  Cyclic AMP modulation of human B cell proliferative responses: role of cAMP-dependent protein kinases in enhancing B cell responses to phorbol diesters and ionomycin. , 1992, Cellular immunology.

[38]  B. Arnason,et al.  Interactions between the Sympathetic Nervous System and the Immune System , 1999, Brain, Behavior, and Immunity.

[39]  M. Gordon,et al.  Effects of beta-adrenergic agents on the murine lymphocyte response to mitogen stimulation. , 1981, Journal of immunopharmacology.

[40]  M. Caron,et al.  Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Felten,et al.  Innervation of Lymphoid Tissue , 1991 .

[42]  R. Jacobs,et al.  Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells , 1993, Journal of Clinical Immunology.

[43]  R. Jacobs,et al.  Modulation of the immunologic response to acute stress in humans by β‐blockade or benzodiazepines , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  K. Madden,et al.  The role of the sympathetic nervous system in the modulation of immune responses. , 1998, Advances in pharmacology.

[45]  C. Heijnen,et al.  β2‐Adrenergic stimulation causes detachment of natural killer cells from cultured endothelium , 1993, European journal of immunology.

[46]  A. Munson,et al.  Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. , 1984, The Journal of pharmacology and experimental therapeutics.

[47]  C. Franceschi,et al.  Aging, Longevity, Inflammation, and Cancer , 2004, Annals of the New York Academy of Sciences.

[48]  D. Kasprowicz,et al.  Stimulation of the B Cell Receptor, CD86 (B7-2), and the β2-Adrenergic Receptor Intrinsically Modulates the Level of IgG1 and IgE Produced per B Cell1 , 2000, The Journal of Immunology.

[49]  P. Auberger,et al.  Modulation of T cell activation by differential regulation of the phosphorylation of two cytosolic proteins. Implication of both Ca2+ and cyclic AMP-dependent protein kinases. , 1989, Journal of Biological Chemistry.

[50]  M. Harbuz Neuroendocrine–immune interactions , 2003, Trends in Endocrinology & Metabolism.

[51]  A. Kavelaars,et al.  Cytokines regulate α1-adrenergic receptor mRNA expression in human monocytic cells and endothelial cells , 2002, Journal of Neuroimmunology.

[52]  J. Kiecolt-Glaser,et al.  Psychoneuroimmunology and cancer: fact or fiction? , 1999, European journal of cancer.

[53]  B. Graf,et al.  Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgG1. , 2002, Immunology letters.

[54]  D. Kasprowicz,et al.  Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. , 1997, Journal of immunology.

[55]  C. Froelich,et al.  Enhancement of natural cytotoxicity by beta-endorphin. , 1983, Journal of immunology.

[56]  W. Markesbery,et al.  Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. , 1986, Immunology.

[57]  J. Saurat,et al.  cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. , 1994, International immunology.

[58]  A. Munson,et al.  Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. , 1988, Cellular immunology.

[59]  S. Felten,et al.  Involvement of peripheral and central catecholamine systems in neural-immune interactions , 1985, Journal of Neuroimmunology.

[60]  P. Sharp,et al.  Transcriptional regulation of the murine 3' IgH enhancer by OCT-2. , 1999, Immunity.

[61]  W. van Eden,et al.  The β2-Adrenergic Agonist Salbutamol Potentiates Oral Induction of Tolerance, Suppressing Adjuvant Arthritis and Antigen-Specific Immunity1 , 2002, The Journal of Immunology.

[62]  J. Dimsdale,et al.  Nonselective β blockade attenuates the recruitment of CD62L− T lymphocytes following exercise , 1999, European Journal of Applied Physiology and Occupational Physiology.

[63]  S. Maier,et al.  Immune regulation of central nervous system functions: from sickness responses to pathological pain , 2005, Journal of internal medicine.

[64]  R. Straub,et al.  Sympathetic neurotransmitters in joint inflammation. , 2005, Rheumatic diseases clinics of North America.

[65]  E. Sorkin,et al.  The immune response evokes changes in brain noradrenergic neurons. , 1983, Science.

[66]  K. Madden,et al.  Noradrenergic Sympathetic Neural Interactions with the Immune System: Structure and Function , 1987, Immunological reviews.

[67]  T. Loop,et al.  Dobutamine Inhibits Phorbol-Myristate-Acetate-Induced Activation of Nuclear Factor-&kgr;B in Human T Lymphocytes In Vitro , 2004, Anesthesia and analgesia.

[68]  D. Herndon,et al.  Contribution of the sympathetic nervous system on the burn-associated impairment of CCL3 production. , 2005, Cytokine.

[69]  G. Marshall,et al.  Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[70]  A. Bousseau,et al.  Modulation of interleukin-1 and tumor necrosis factor expression by β-adrenergic agonists in mouse ameboid microglial cells , 2004, Experimental Brain Research.

[71]  B. Zwilling,et al.  Binding of α-adrenergic receptors stimulates the anti-mycobacterial activity of murine peritoneal macrophages , 1996, Journal of Neuroimmunology.

[72]  J. Fries,et al.  An analysis of the American Rheumatism Association criteria for rheumatoid arthritis. , 1982, Arthritis and rheumatism.

[73]  A. Munson,et al.  Kinetics of the enhancing effect produced by norepinephrine and terbutaline on the murine primary antibody response in vitro. , 1984, The Journal of pharmacology and experimental therapeutics.

[74]  J. Schölmerich,et al.  Stress and rheumatic diseases. , 2000, Rheumatic diseases clinics of North America.

[75]  R. MacCallum,et al.  Stress-related changes in proinflammatory cytokine production in wounds. , 1999, Archives of general psychiatry.

[76]  H. Nakane,et al.  An Interleukin-1β-Induced Noradrenaline Release in the Spleen Is Mediated by Brain Corticotropin-Releasing Factor: An in Vivo Microdialysis Study in Conscious Rats , 1994, Brain, Behavior, and Immunity.

[77]  K. Madden,et al.  Sympathetic neural modulation of the immune system I. Depression of T cell immunity in vivo and in vitro following chemical sympathectomy , 1989, Brain, Behavior, and Immunity.

[78]  H. Haas,et al.  Hypothalamic changes during the immune response. , 1977, European journal of immunology.

[79]  J. Watson The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis , 1975, The Journal of experimental medicine.

[80]  R. MacCallum,et al.  Psychological influences on surgical recovery. Perspectives from psychoneuroimmunology. , 1998, The American psychologist.

[81]  K. Matthews,et al.  Sympathetic Reactivity to Acute Stress and Immune Response in Women , 1995, Psychosomatic medicine.

[82]  K. Arai,et al.  Signal transduction in Th clones: target of differential modulation by PGE2 may reside downstream of the PKC-dependent pathway. , 1996, Cytokine.

[83]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[84]  G. Baker Life events before the onset of rheumatoid arthritis. , 1982, Psychotherapy and psychosomatics.

[85]  G. Maestroni Dendritic Cell Migration Controlled by α1b-Adrenergic Receptors1 , 2000, The Journal of Immunology.

[86]  A. Munson,et al.  Role of alpha adrenoceptor activation in modulating the murine primary antibody response in vitro. , 1985, The Journal of pharmacology and experimental therapeutics.

[87]  E. Bywaters,et al.  Unilateral Rheumatoid Arthritis following Hemiplegia , 1962, Annals of the rheumatic diseases.

[88]  K. Bulloch,et al.  Changes in β‐adrenergic receptor distribution on immunocytes during differentiation: An analysis of T cells and macrpphages , 1991 .

[89]  B. Arnason,et al.  Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis , 1988, Journal of Neuroimmunology.

[90]  K. Madden,et al.  Alterations in T lymphocyte activity following chemical sympathectomy in young and old Fischer 344 rats , 2000, Journal of Neuroimmunology.

[91]  Sung-Hwan Park,et al.  Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[92]  P. Rice,et al.  Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenes , 2001, Journal of Neuroimmunology.

[93]  E. Rothenberg,et al.  cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[94]  S. Ferguson,et al.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.

[95]  E. Sorkin,et al.  Immunoregulation mediated by the sympathetic nervous system, II. , 1979, Cellular immunology.

[96]  B. Pedersen,et al.  Influence of Minor Increases in Plasma Catecholamines on Natural Killer Cell Activity , 1997, Hormone Research in Paediatrics.

[97]  R. Palmiter,et al.  Dopamine beta-hydroxylase deficiency impairs cellular immunity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[98]  R. Strieter,et al.  Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. , 1990, Journal of immunology.

[99]  S. Felten,et al.  A longitudinal study of age-related loss of noradrenergic nerves and lymphoid cells in the rat spleen , 1992, Experimental Neurology.

[100]  M. Schedlowski,et al.  Adjuvant Arthritis Induces Down-Regulation of G Protein-Coupled Receptor Kinases in the Immune System1 , 2001, The Journal of Immunology.

[101]  Nicholas W. Kin,et al.  CD86 and β2-Adrenergic Receptor Signaling Pathways, Respectively, Increase Oct-2 and OCA-B Expression and Binding to the 3′-IgH Enhancer in B Cells* , 2004, Journal of Biological Chemistry.

[102]  H. Mathews,et al.  Stress reduction and HIV disease: a review of intervention studies using a psychoneuroimmunology framework. , 2000, The Journal of the Association of Nurses in AIDS Care : JANAC.

[103]  Behaviorally Conditioned Immunosuppression , 1974 .

[104]  K. Furusho,et al.  Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. , 1995, Journal of immunology.

[105]  W. Schaffner,et al.  B lymphocytes are impaired in mice lacking the transcriptional co‐activator Bob1/OCA‐B/OBF1 , 1996, European journal of immunology.

[106]  M. Sitkovsky,et al.  Locus of inhibitory action of cAMP-dependent protein kinase in the antigen receptor-triggered cytotoxic T lymphocyte activation pathway. , 1988, The Journal of biological chemistry.

[107]  G. Cremaschi,et al.  Down‐regulation of β‐adrenergic receptors induced by mitogen activation of intracellular signaling events in lymphocytes , 1995 .

[108]  R. Ader,et al.  Psychoneuroimmunology, 2nd ed. , 1991 .

[109]  G. Gualco,et al.  Adrenergic innervation in reactive human lymph nodes , 1999, Journal of anatomy.

[110]  M. Yokoyama,et al.  Norepinephrine inhibits human natural killer cell activity in vitro. , 1991, The International journal of neuroscience.

[111]  G. Hunninghake,et al.  Beta-adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. , 1987, Journal of immunology.

[112]  D. Lawrence,et al.  Sympathetic nervous system plays a major role in acute cold/restraint stress inhibition of host resistance to Listeria monocytogenes , 2002, Journal of Neuroimmunology.

[113]  A. Khamlichi,et al.  Localization of the 3' IgH locus elements that effect long-distance regulation of class switch recombination. , 2001, Immunity.

[114]  E. Smeland,et al.  Cyclic AMP‐mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha‐ras protooncogenes , 1987, Journal of cellular physiology.

[115]  R. Jacobs,et al.  Expression and in-vivo modulation of α- and β-adrenoceptors on human natural killer (CD16+) cells , 1997, Journal of Neuroimmunology.

[116]  T. Gajewski,et al.  Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. , 1990, Journal of immunology.

[117]  R. Perlman,et al.  Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma , 1995, Cancer Immunology, Immunotherapy.

[118]  M. Feldmann,et al.  Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.

[119]  J. Bergquist,et al.  Catecholaminergic suppression of immunocompetent cells. , 1998, Immunology today.

[120]  K. Kelley,et al.  Down-Regulation of Glucocorticoid and β-Adrenergic Receptors on Lectin-Stimulated Splenocytes 1 , 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[121]  A. Fauci,et al.  Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle. , 1984, Journal of immunology.

[122]  R. Townley,et al.  Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. , 1996, Immunopharmacology.

[123]  D. Papanicolaou,et al.  Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. , 1996, Proceedings of the Association of American Physicians.

[124]  R. Summers,et al.  CHARACTERIZATION AND LOCALIZATION OF [3H]‐CLONIDINE BINDING IN MEMBRANES PREPARED FROM GUINEA‐PIG SPLEEN , 1982, Clinical and experimental pharmacology & physiology.

[125]  G. Delespesse,et al.  beta-Adrenoreceptors display different efficiency on lymphocyte subpopulations. , 1983, Biochemical pharmacology.

[126]  B. H. Petersen,et al.  Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro. , 1986, The Journal of pharmacology and experimental therapeutics.

[127]  C. Deutsch,et al.  Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. , 1991, Journal of immunology.

[128]  J. Kiecolt-Glaser,et al.  Stress-induced immune dysfunction: implications for health , 2005, Nature Reviews Immunology.

[129]  P. Lipsky,et al.  Characterization of the 3',5'-cyclic adenosine monophosphate-mediated regulation of IL2 production by T cells and Jurkat cells. , 1991, Cellular immunology.

[130]  D. Chen,et al.  Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles , 1994, The Journal of experimental medicine.

[131]  K. Melmon,et al.  The effects of autacoids on cloned murine lymphoid cells: modulation of IL 2 secretion and the activity of natural suppressor cells. , 1985, Journal of immunology.

[132]  W. Kuis,et al.  Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for α1-adrenergic receptors , 2000, Journal of Neuroimmunology.

[133]  M. Betz,et al.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. , 1991, Journal of immunology.

[134]  J. Schölmerich,et al.  An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. , 2005, Arthritis and rheumatism.

[135]  M. Schedlowski,et al.  Catecholamine-Induced Leukocytosis: Early Observations, Current Research, and Future Directions , 1996, Brain, Behavior, and Immunity.

[136]  V. Sanders,et al.  IFN-γ Production by Th1 Cells Generated from Naive CD4+ T Cells Exposed to Norepinephrine1 , 2001, The Journal of Immunology.

[137]  S. Cole,et al.  Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. , 1998, Journal of immunology.

[138]  M. Caron,et al.  G Protein-Coupled Receptor Kinase 2 in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis , 2005, The Journal of Immunology.

[139]  A. Goldstein,et al.  Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses. , 1982, Immunopharmacology.

[140]  R. Straub Complexity of the bi-directional neuroimmune junction in the spleen. , 2004, Trends in pharmacological sciences.

[141]  S. Sirlin,et al.  Specificity of immunoglobulin heavy chain switch correlates with activity of germline heavy chain genes prior to switching. , 1986, The EMBO journal.

[142]  A. Tamir,et al.  Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes. , 1994, Journal of immunology.

[143]  P. Howarth,et al.  The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. , 1999, The European respiratory journal.

[144]  Lawrence Steinman,et al.  Elaborate interactions between the immune and nervous systems , 2004, Nature Immunology.

[145]  L. Corcoran,et al.  oct-2 gene disruption eliminates the peritoneal B-1 lymphocyte lineage and attenuates B-2 cell maturation and function. , 1997, Journal of immunology.

[146]  J. Schölmerich,et al.  Ablation of the sympathetic nervous system decreases gram-negative and increases gram-positive bacterial dissemination: key roles for tumor necrosis factor/phagocytes and interleukin-4/lymphocytes. , 2005, The Journal of infectious diseases.

[147]  K. Kasahara,et al.  Suppression of the primary immune response by chemical sympathectomy. , 1977, Research communications in chemical pathology and pharmacology.

[148]  R. Roeder,et al.  Role of OCA-B in 3′-IgH Enhancer Function1 , 2000, The Journal of Immunology.

[149]  V. Sanders,et al.  Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. , 1997, Journal of immunology.

[150]  M. Kohut,et al.  Exercise training-induced adaptations of immune response are mediated by beta-adrenergic receptors in aged but not young mice. , 2004, Journal of applied physiology.

[151]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[152]  A. Kavelaars Regulated expression of α-1 adrenergic receptors in the immune system , 2002, Brain, Behavior, and Immunity.

[153]  V. Sanders,et al.  Selective Regulation of Mature IgG1 Transcription by CD86 and β2-Adrenergic Receptor Stimulation1 , 2003, The Journal of Immunology.

[154]  Gerald Maurer,et al.  Catecholamines potentiate LPS‐induced expression of MMP‐1 and MMP‐9 in human monocytes and in the human monocytic cell line U937: possible implications for peri‐ operative plaque instability , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[155]  J. Sheridan,et al.  Mechanisms of stress-induced modulation of viral pathogenesis and immunity , 1993, Journal of Neuroimmunology.

[156]  T. van der Poll,et al.  Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood , 1994, Infection and immunity.

[157]  R. Phipps,et al.  Antigen-specific IGG2A production in response to prostaglandin E2, immune complexes, and IFN-gamma. , 1991, Journal of immunology.

[158]  M. Trojano,et al.  Post-receptorial mechanisms underlie functional disregulation of β2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients , 2004, Journal of Neuroimmunology.

[159]  A. Basbaum,et al.  Beta 2-adrenergic mechanisms in experimental arthritis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[160]  E. Borda,et al.  Active alpha2 and beta adrenoceptors in lymphocytes from patients with chronic lymphocytic leukemia , 1991, International journal of cancer.

[161]  D. Conrad,et al.  Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis. , 1990, Journal of immunology.

[162]  M. Biondi,et al.  Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animals and man: a review. , 1997, Psychotherapy and psychosomatics.

[163]  G. Maestroni Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development , 2002, Journal of Neuroimmunology.

[164]  V. Sanders,et al.  Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. , 1999, Journal of immunology.

[165]  W. Kuis,et al.  Functional α1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis , 1996, Journal of Neuroimmunology.

[166]  A. Lefvert,et al.  β2 Adrenoceptor gene single nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden , 2004, Annals of the rheumatic diseases.

[167]  U. Dirnagl,et al.  Stroke-induced Immunodeficiency Promotes Spontaneous Bacterial Infections and Is Mediated by Sympathetic Activation Reversal by Poststroke T Helper Cell Type 1–like Immunostimulation , 2003, The Journal of experimental medicine.

[168]  Z. Ba,et al.  Upregulation of Kupffer cell beta-adrenoceptors and cAMP levels during the late stage of sepsis. , 1998, Biochimica et biophysica acta.

[169]  A. Kavelaars,et al.  Role and modulation of G protein-coupled receptor signaling in inflammatory processes. , 2002, Critical reviews in immunology.

[170]  Andreas Radbruch,et al.  The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. , 1999, Rheumatology.

[171]  G. Marinetti,et al.  alpha 2-Adrenergic receptors in human polymorphonuclear leukocyte membranes. , 1983, Biochemical pharmacology.

[172]  G. Chrousos,et al.  The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. , 2000, Pharmacological reviews.

[173]  D. Postma,et al.  Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. , 1996, Blood.

[174]  S. Romagnani,et al.  T-cell subsets (Th1 versus Th2). , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[175]  G. Maestroni,et al.  Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. , 2003, Journal of neuroimmunology.

[176]  J. Sheridan,et al.  Stress and immunity: implications for viral disease and wound healing. , 1999, Journal of periodontology.

[177]  J. Sheridan,et al.  Stress‐Induced Neuroendocrine Modulation of Viral Pathogenesis and Immunity a , 1998, Annals of the New York Academy of Sciences.

[178]  V. Sanders,et al.  Activation of Antigen-Specific CD4+ Th2 Cells and B Cells In Vivo Increases Norepinephrine Release in the Spleen and Bone Marrow1 , 2000, The Journal of Immunology.

[179]  J. Revillard,et al.  Cyclic AMP can enhance mouse B cell activation by regulating progression into the late G1/S phase , 1989, European journal of immunology.

[180]  D. Cohen,et al.  Adenosine 3',5'-cyclic monophosphate modulates the mitogenic responses of murine B lymphocytes. , 1989, Cellular immunology.

[181]  J. Revillard,et al.  Selective T cell defects induced by dopamine administration in mice. , 1987, Immunopharmacology and immunotoxicology.

[182]  N. Muthusamy,et al.  Differential regulation of surface Ig- and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. , 1991, Journal of immunology.

[183]  L. V. van Doornen,et al.  Effects of beta-adrenergic blockade on immunologic and cardiovascular changes induced by mental stress. , 1994, Circulation.

[184]  B. Arnason,et al.  The sympathetic nervous system modulates antibody response to thymus-independent antigens , 1981, Journal of Neuroimmunology.

[185]  A. Kavelaars,et al.  β 2-Adrenergic activation enhances interleukin-8 production by human monocytes , 1997, Journal of Neuroimmunology.

[186]  V. Sanders,et al.  B Cell Receptor- and β2-Adrenergic Receptor-Induced Regulation of B7-2 (CD86) Expression in B Cells1 , 2002, The Journal of Immunology.

[187]  D. Postma,et al.  Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. , 1998, American journal of respiratory cell and molecular biology.

[188]  K. Kasahara,et al.  Suppressed immune response to T-cell dependent antigen in chemically sympathectomized mice. , 1977, Research communications in chemical pathology and pharmacology.

[189]  K. Madden,et al.  Neonatal sympathetic denervation alters the development of in vitro spleen cell proliferation and differentiation , 1991, Brain, Behavior, and Immunity.

[190]  L. Fabbri,et al.  Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. , 1997, The Journal of clinical investigation.

[191]  H. Besedovsky,et al.  Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.

[192]  S. Titinchi,et al.  Alpha 2-adrenoceptors in human lymphocytes: direct characterisation by [3H]yohimbine binding. , 1984, Biochemical and biophysical research communications.

[193]  B. Huber,et al.  Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation , 1990, The Journal of experimental medicine.

[194]  F. Dhabhar,et al.  Enhancing versus suppressive effects of stress hormones on skin immune function. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[195]  G. Marshall,et al.  Beta-adrenergic modulation of human type-1/type-2 cytokine balance. , 2000, The Journal of allergy and clinical immunology.

[196]  V. Sanders,et al.  Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. , 2001, Pharmacological reviews.

[197]  T. van der Poll,et al.  Epinephrine inhibits endotoxin-induced IL-1β production: roles of tumor necrosis factor-α and IL-10. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[198]  J. Campisi,et al.  Splenic norepinephrine depletion following acute stress suppresses in vivo antibody response , 2005, Journal of Neuroimmunology.

[199]  H. Ullum,et al.  Adrenaline‐induced mobilization of T cells in HIV‐infected patients , 2000, Clinical and experimental immunology.

[200]  P. Newsholme,et al.  Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst in human neutrophils by adrenaline: inhibition of Phospholipase A2 activity but not p47phox phosphorylation and translocation. , 2004, Biochemical pharmacology.

[201]  N. Christensen,et al.  Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers , 1987, European journal of clinical investigation.

[202]  A. Maisel,et al.  Beta-adrenoceptor control of immune function in congestive heart failure. , 1990, British journal of clinical pharmacology.

[203]  L. Corcoran,et al.  Oct-2 is required early in T cell-independent B cell activation for G1 progression and for proliferation. , 1994, Immunity.

[204]  G. Firestein Evolving concepts of rheumatoid arthritis , 2003, Nature.

[205]  Naphtali Abudarham,et al.  Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a β-adrenergic antagonist and a prostaglandin synthesis inhibitor , 2005, Brain, Behavior, and Immunity.

[206]  Shiaoching Gong,et al.  The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes , 1996, Nature.

[207]  T. van der Poll,et al.  Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone , 1997, Infection and immunity.

[208]  D. Herndon,et al.  Increased norepinephrine production associated with burn injuries results in CCL2 production and type 2 T cell generation. , 2004, Burns : journal of the International Society for Burn Injuries.

[209]  V. Kalinichenko,et al.  Norepinephrine-Mediated Inhibition of Antitumor Cytotoxic T Lymphocyte Generation Involves a β-Adrenergic Receptor Mechanism and Decreased TNF-α Gene Expression , 1999, The Journal of Immunology.

[210]  R. Phipps,et al.  Anti-class II antibodies potentiate IgG2a production by lipopolysaccharide-stimulated B lymphocytes treated with prostaglandin E2 and IFN-gamma. , 1992, Journal of immunology.

[211]  C. Baerwald,et al.  Autonomic dysfunction in rheumatic diseases. , 2005, Rheumatic diseases clinics of North America.

[212]  C. Parker,et al.  Modulation of IL-4 production in murine spleen cells by prostaglandins. , 1995, Cellular immunology.

[213]  A. Kavelaars,et al.  Neuroendocrine mediators up-regulate α1b- and α1d-adrenergic receptor subtypes in human monocytes , 1999, Journal of Neuroimmunology.